Table 8 Change in HbA1c with DPP-4i use, N = 47 (patients without insulin)
From: Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital
Type of DPP-4i | n (%) | Pre DPP-4i use | Post DPP-4i use | Mean difference (95% CI) | P value£ | P value¥ |
|---|---|---|---|---|---|---|
Vildagliptin | 20 (42.6) | 7.7 ± 0.9 | 6.7 ± 0.8 | 1.03 (0.37, 1.68) | 0.004* | 0.104¢ |
Sitagliptin | 13 (27.7) | 8.8 ± 2.1 | 7.1 ± 1.4 | 1.69 (0.25, 3.13) | 0.025* | |
Saxagliptin | 13 (27.7) | 7.8 ± 1.3 | 7.4 ± 1.1 | 0.32(−0.06, 0.71) | 0.094 | |
Linagliptin | 1 (2.1) |